Eflumast

This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3CIG2V70UB. European Medicines Agency schedules Eflumast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06470MIG. Eflumast generally arises in the molecular formula C10H8FN5O3. The term EFLUMAST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, no. 3 1990, list 30.) EFLUMAST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule eflumast under HS 29339990 and SITC 51577. As of Q4 2014, EFLUMAST remains the US FDA Preferred Term for this commodity. Eflumast bears US NLM identifiers UMLS ID C0654074 and NCI Concept Code C73049. SMILES: CC(=O)C1=CC(=CC(=NC(=O)C2=NNNN2)C1=O)F.